Financial Ratios Thyrocare Technologies Limited
Equities
THYROCARE
INE594H01019
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 369.45 INR | -1.31% |
|
-1.83% | -17.16% |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 17.35 | 21.78 | 8.28 | 8.98 | 12.64 | |||||
Return on Total Capital | 21.65 | 25.56 | 9.29 | 10.16 | 14.8 | |||||
Return On Equity % | 28.5 | 36.93 | 12.12 | 13.08 | 16.89 | |||||
Return on Common Equity | 28.5 | 36.93 | 12.13 | 13.34 | 17.05 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 53.41 | 58.92 | 46 | 48.17 | 50.26 | |||||
SG&A Margin | 1.31 | 1.41 | 2.29 | 3.65 | 3.09 | |||||
EBITDA Margin % | 33.6 | 38.93 | 21.56 | 22.75 | 26.4 | |||||
EBITA Margin % | 28.56 | 34.16 | 15.63 | 16.06 | 19.71 | |||||
EBIT Margin % | 28.53 | 34.14 | 15.61 | 16.03 | 19.67 | |||||
Income From Continuing Operations Margin % | 22.88 | 29.91 | 12.22 | 12.15 | 13.2 | |||||
Net Income Margin % | 22.88 | 29.91 | 12.22 | 12.37 | 13.31 | |||||
Net Avail. For Common Margin % | 22.88 | 29.91 | 12.22 | 12.37 | 13.31 | |||||
Normalized Net Income Margin | 18.06 | 21.33 | 9.82 | 10.18 | 12.53 | |||||
Levered Free Cash Flow Margin | 12.09 | 13.85 | 14.21 | 10.18 | 16.06 | |||||
Unlevered Free Cash Flow Margin | 12.2 | 14.1 | 14.49 | 10.64 | 16.34 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.97 | 1.02 | 0.85 | 0.9 | 1.03 | |||||
Fixed Assets Turnover | 2.97 | 3.4 | 2.76 | 2.87 | 3.42 | |||||
Receivables Turnover (Average Receivables) | 16.22 | 8.54 | 5.91 | 8.89 | 11.8 | |||||
Inventory Turnover (Average Inventory) | 9.65 | 8.15 | 8.8 | 7.18 | 6.44 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.5 | 4.19 | 3.54 | 3.08 | 2.77 | |||||
Quick Ratio | 1.77 | 3.62 | 2.93 | 2.1 | 1.87 | |||||
Operating Cash Flow to Current Liabilities | 1.22 | 1.76 | 1.68 | 1.85 | 1.57 | |||||
Days Sales Outstanding (Average Receivables) | 22.5 | 42.73 | 61.79 | 41.15 | 30.92 | |||||
Days Outstanding Inventory (Average Inventory) | 37.81 | 44.8 | 41.49 | 50.97 | 56.64 | |||||
Average Days Payable Outstanding | 36.77 | 30.16 | 26.39 | 36.83 | 61.82 | |||||
Cash Conversion Cycle (Average Days) | 23.54 | 57.38 | 76.89 | 55.29 | 25.74 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 1.99 | 3.93 | 4.36 | 8.02 | 4.51 | |||||
Total Debt / Total Capital | 1.95 | 3.78 | 4.17 | 7.43 | 4.32 | |||||
LT Debt/Equity | 1.28 | 2.98 | 3.01 | 4.3 | 3.09 | |||||
Long-Term Debt / Total Capital | 1.25 | 2.87 | 2.89 | 3.98 | 2.96 | |||||
Total Liabilities / Total Assets | 21.71 | 13.34 | 15.41 | 18.05 | 21.03 | |||||
EBIT / Interest Expense | 162.21 | 84.82 | 34.97 | 21.83 | 44.04 | |||||
EBITDA / Interest Expense | 196.95 | 99.11 | 51.15 | 32.92 | 61.86 | |||||
(EBITDA - Capex) / Interest Expense | 164.47 | 83.15 | 32.58 | 18.26 | 47.24 | |||||
Total Debt / EBITDA | 0.05 | 0.09 | 0.19 | 0.31 | 0.13 | |||||
Net Debt / EBITDA | -0.64 | -0.5 | -0.97 | -0.75 | -0.69 | |||||
Total Debt / (EBITDA - Capex) | 0.06 | 0.11 | 0.3 | 0.55 | 0.17 | |||||
Net Debt / (EBITDA - Capex) | -0.76 | -0.6 | -1.53 | -1.35 | -0.9 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 13.9 | 19.05 | -10.56 | 8.58 | 20.19 | |||||
Gross Profit, 1 Yr. Growth % | 1.69 | 31.32 | -30.18 | 13.71 | 25.39 | |||||
EBITDA, 1 Yr. Growth % | -0.99 | 37.92 | -50.46 | 14.55 | 39.5 | |||||
EBITA, 1 Yr. Growth % | -0.38 | 42.39 | -59.07 | 11.55 | 47.47 | |||||
EBIT, 1 Yr. Growth % | -0.38 | 42.45 | -59.11 | 11.57 | 47.41 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 28 | 55.67 | -63.46 | 7.97 | 30.59 | |||||
Net Income, 1 Yr. Growth % | 28 | 55.67 | -63.46 | 9.72 | 29.32 | |||||
Normalized Net Income, 1 Yr. Growth % | 0.55 | 40.59 | -58.81 | 12.25 | 47.93 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 27.89 | 55.59 | -63.49 | 9.66 | 29.16 | |||||
Accounts Receivable, 1 Yr. Growth % | 174.11 | 108.59 | -8.67 | -48.93 | 67.93 | |||||
Inventory, 1 Yr. Growth % | 9.57 | 37.94 | -12.2 | 73.11 | 2.79 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -7.24 | 16.68 | 4.09 | 4.77 | -2.65 | |||||
Total Assets, 1 Yr. Growth % | 15.91 | 11.33 | 4.12 | 1.76 | 7.59 | |||||
Tangible Book Value, 1 Yr. Growth % | 22.93 | 30.5 | 1.83 | -2.58 | 2.76 | |||||
Common Equity, 1 Yr. Growth % | 16.54 | 23.24 | 1.47 | -1.41 | 3.79 | |||||
Cash From Operations, 1 Yr. Growth % | -30.89 | -1.15 | 14.02 | 29.63 | 14.13 | |||||
Capital Expenditures, 1 Yr. Growth % | 185.45 | 41.74 | 15.38 | 41.08 | -27.1 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -60.25 | 38.06 | -8.24 | -22.23 | 89.69 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -60.2 | 39.28 | -8.1 | -20.28 | 84.66 | |||||
Dividend Per Share, 1 Yr. Growth % | 399.99 | -40 | 20 | 0 | 16.67 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.66 | 16.45 | 3.19 | -1.45 | 14.24 | |||||
Gross Profit, 2 Yr. CAGR % | 4.17 | 15.56 | -4.24 | -10.89 | 19.41 | |||||
EBITDA, 2 Yr. CAGR % | 3.66 | 16.85 | -17.34 | -24.67 | 26.41 | |||||
EBITA, 2 Yr. CAGR % | 4.54 | 19.1 | -23.66 | -32.43 | 28.27 | |||||
EBIT, 2 Yr. CAGR % | 4.55 | 19.12 | -23.68 | -32.46 | 28.25 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 15.28 | 41.16 | -24.58 | -37.19 | 18.74 | |||||
Net Income, 2 Yr. CAGR % | 15.28 | 41.16 | -24.58 | -36.62 | 19.12 | |||||
Normalized Net Income, 2 Yr. CAGR % | 3.72 | 18.9 | -23.9 | -31.92 | 28.86 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 15.9 | 41.06 | -24.63 | -36.66 | 19.01 | |||||
Accounts Receivable, 2 Yr. CAGR % | 91.69 | 139.12 | 38.03 | -31.71 | -7.39 | |||||
Inventory, 2 Yr. CAGR % | 12.65 | 22.94 | 10.05 | 23.28 | 33.39 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -7.54 | 4.04 | 10.2 | 4.43 | 0.99 | |||||
Total Assets, 2 Yr. CAGR % | 7.23 | 13.6 | 7.67 | 2.94 | 4.64 | |||||
Tangible Book Value, 2 Yr. CAGR % | -0.09 | 26.66 | 15.27 | -0.4 | 0.06 | |||||
Common Equity, 2 Yr. CAGR % | -0.9 | 19.84 | 11.82 | 0.02 | 1.16 | |||||
Cash From Operations, 2 Yr. CAGR % | 7.55 | -17.81 | 6.16 | 21.58 | 21.64 | |||||
Capital Expenditures, 2 Yr. CAGR % | -16.21 | 95.48 | 27.88 | 27.59 | 1.41 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 19.31 | -26.38 | 12.56 | -15.52 | 21.47 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 19.31 | -26 | 13.14 | -14.41 | 21.33 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.8 | 73.2 | -15.15 | 9.54 | 8.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 11.49 | 13.39 | 6.64 | 4.96 | 5.29 | |||||
Gross Profit, 3 Yr. CAGR % | 5.8 | 12.53 | -2.31 | 1.4 | -0.15 | |||||
EBITDA, 3 Yr. CAGR % | 4.23 | 14.01 | -12.21 | -7.84 | -7.49 | |||||
EBITA, 3 Yr. CAGR % | 3.59 | 15.88 | -16.57 | -13.37 | -12.35 | |||||
EBIT, 3 Yr. CAGR % | 3.6 | 15.9 | -16.6 | -13.38 | -12.39 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 6.65 | 27.42 | -10.04 | -15 | -19.83 | |||||
Net Income, 3 Yr. CAGR % | 6.65 | 27.42 | -10.04 | -14.48 | -19.61 | |||||
Normalized Net Income, 3 Yr. CAGR % | 2.51 | 14.79 | -16.49 | -13.3 | -11.82 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 7.25 | 27.85 | -10.1 | -14.53 | -19.68 | |||||
Accounts Receivable, 3 Yr. CAGR % | 65.59 | 97.16 | 73.49 | -0.91 | -7.82 | |||||
Inventory, 3 Yr. CAGR % | 9.71 | 20.52 | 9.89 | 27.99 | 16.03 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -5.58 | -0.08 | 4.05 | 8.36 | 2.01 | |||||
Total Assets, 3 Yr. CAGR % | 4.45 | 8.58 | 10.35 | 5.66 | 4.47 | |||||
Tangible Book Value, 3 Yr. CAGR % | -0.87 | 9.21 | 17.77 | 8.99 | 0.64 | |||||
Common Equity, 3 Yr. CAGR % | -1.22 | 6.57 | 13.37 | 7.23 | 1.26 | |||||
Cash From Operations, 3 Yr. CAGR % | 2.73 | 4.18 | -8.33 | 13.47 | 19.04 | |||||
Capital Expenditures, 3 Yr. CAGR % | -13.49 | -2.05 | 63.98 | 32.14 | 5.87 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -1.74 | 24.74 | -20.77 | -0.49 | 10.63 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -1.59 | 25.11 | -20.46 | 0.67 | 10.6 | |||||
Dividend Per Share, 3 Yr. CAGR % | 35.72 | -9.14 | 53.26 | -10.37 | 11.87 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 15.46 | 14.1 | 8.09 | 7.2 | 9.62 | |||||
Gross Profit, 5 Yr. CAGR % | 13.15 | 13.05 | 1.66 | 2.5 | 5.86 | |||||
EBITDA, 5 Yr. CAGR % | 11.87 | 14.22 | -5 | -3.4 | 1.57 | |||||
EBITA, 5 Yr. CAGR % | 12.92 | 14.96 | -8.31 | -6.61 | -0.91 | |||||
EBIT, 5 Yr. CAGR % | 12.9 | 14.94 | -8.32 | -6.61 | -0.93 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.91 | 32.68 | -7.15 | -3.98 | 0.53 | |||||
Net Income, 5 Yr. CAGR % | 16.91 | 32.68 | -7.15 | -3.63 | 0.69 | |||||
Normalized Net Income, 5 Yr. CAGR % | 11.69 | 13.14 | -9.01 | -6.85 | -0.62 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 16.26 | 32.98 | -6.86 | -3.46 | 0.62 | |||||
Accounts Receivable, 5 Yr. CAGR % | 42.87 | 71.54 | 53.96 | 29.02 | 34.97 | |||||
Inventory, 5 Yr. CAGR % | 7.34 | 17.95 | 9.85 | 21.62 | 18.75 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 0.99 | 2.07 | 0.44 | 1.7 | 2.82 | |||||
Total Assets, 5 Yr. CAGR % | 5.91 | 6.78 | 5.72 | 6.29 | 8.03 | |||||
Tangible Book Value, 5 Yr. CAGR % | 4.83 | 7.22 | 5.29 | 5.26 | 10.34 | |||||
Common Equity, 5 Yr. CAGR % | 3.17 | 5.24 | 3.81 | 3.9 | 8.32 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.34 | 4.83 | 3.85 | 10.82 | 2.65 | |||||
Capital Expenditures, 5 Yr. CAGR % | 14.4 | 0.79 | 0 | 8.88 | 35.3 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -2.13 | 20.8 | 3.49 | 6.73 | -6 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -1.95 | 21.11 | 3.8 | 7.49 | -5.82 | |||||
Dividend Per Share, 5 Yr. CAGR % | 58.49 | 8.45 | 12.47 | -2.09 | 33.24 |
Select your edition
All financial news and data tailored to specific country editions
















